Abstract
Atopic dermatitis (AD), a common chronic inflammatory skin disease that may persist into adulthood, is associated with intense itching and a high incidence of sleep disturbances [1, 2]. The worldwide prevalence of AD is 15-20% among children [3] and 1-3% among adults. Psychological distress is a common comorbidity associated with atopic dermatitis and can negatively impact the quality of life [4]. Previous large-scale population-based studies have identified an association between AD and psychiatric illness [5–8]. Children with AD in the United States had a significantly higher prevalence of attention-deficit/hyperactivity disorder (ADHD, depression, anxiety, behavioural disorders, and autism) than children without AD [5]. Other authors [6] found that Taiwanese patients with AD had an increased risk of developing the major depressive disorder (MDD) and anxiety disorders. And also, depressive symptoms were significantly higher in patients with AD than in the control group [7, 8].This study aimed to evaluate the association of AD with anxiety and depression using a data mining approach to match patients with AD with controls by sex and age.
References
Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. According to a US population-based study, sleep disturbances in adults with eczema are associated with impaired overall health. J Invest Dermatol. 2015; 135:56–66. doi:10.1038/jid.2014.325;
Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016; 75:681–7.e11. doi:10.1016/j.jaad.2016.05.028;
Asher MI, Montfort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicounty cross-sectional surveys. Lancet. 2006; 368:733–743. doi:10.1016/S0140-6736(06)69283-0;
Wittkowski A, Richards HL, Griffiths CE, et al. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res. 2004; 57:195–200. doi:10.1016/j.jpsychores.2004.04.371;
Yaghmaie P, Koudelka CW, Simpson EL. Mental health comorbidity in patients with atopic dermatitis. J Allergy Clin Immunol. 2013; 131:428–433. doi:10.1016/j.jaci.2012.10.041;
Cheng CM, Hsu JW, Huang KL, et al. Risk of developing the major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study. J Affect Disord. 2015; 178:60–65. doi:10.1016/j.jad.2015.02.025;
Kim S, Lee JY, Oh JY, Chekal L, Lee DC. The association between atopic dermatitis and depressive symptoms in Korean adults: the fifth Korea national health and nutrition examination survey, 2007–2012. Korean J Fam Med. 2015; 36:261–265. doi:10.4082/kjfm.2015.36.6.261;
Lee S, Shin A. Association of atopic dermatitis with depressive symptoms and suicidal behaviours among adolescents in Korea: the 2013 Korean youth risk behaviour survey. BMC Psychiatry. 2017; 17:3. doi:10.1186/s12888-017-1489-6;
Gupta MA, Gupta AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001; 15:512–518. doi:10.1046/j.1468-3083.2001.00278.x;
Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol. 1999; 140:268–272. doi:10.1046/j.1365-2133.1999.02661.x;
Thyssen JP, Hamann CR, Linneberg A, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with hospitalisation or suicide. Allergy. 2017. doi:10.1111/ all.13231;
Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998; 139:846–850;
Klocklokk M, Gotestam KG, Mykletun A. Factors accounting for the association between anxiety and depression, and eczema: the Hordaland health study (HUSK). BMC Dermatol. 2010; 10:3. doi:10.1186/1471-5945-10-3;
Holloway JW, Holgate ST. Genetics of allergic disease. J Allergy Clin Immunol. 2010; 125:S81–S94. doi:10.1016/j.jaci.2009.10.071;
Lau M, Tsantikos E, Maxwell MJ, Tarlinton DM, Anderson GP, Hibbs ML. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background. J Autoimmun. 2012; 39:388–397. doi:10.1016/j.jaut.2012.06.003
Lau M, Tsantikos E, Maxwell MJ, Tarlinton DM, Anderson GP, Hibbs ML. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background. J Autoimmun. 2012; 39:388–397. doi:10.1016/j.jaut.2012.06.003;
Yukawa K, Kishino M, Goda M, et al. STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy. Int J Mol Med. 2005;15:225–230;
Thomsen SF, Kyvik KO, Backer V. Etiological relationships in atopy: a review of twin studies. Twin Res Hum Genet. 2008; 11:1112–1120. doi:10.1375/twin.11.2.112;
Miyazaki C, Koyama M, Ota E, et al. Allergic diseases in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis. BMC Psychiatry. 2017; 17:120. doi:10.1186/s12888-017-1489-6.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.